MedTrace Logo

Optimization and Harmonization of Advanced MRI Sequences

NCT06217237 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2024-01-22

No results posted yet for this study

Summary

Development of a shared multimodal MRI protocol for the definition and quantification of imaging biomarkers in AD, DLB, FDT dementias, especially white matter alterations.

Conditions

Interventions

DIAGNOSTIC_TEST

AD FDT DBL GROUP

All participants will undergo an MRI session. The MRI protocol will include the clinical diagnostic protocol defined within the Network and research sequences as specified above (T1 3D, DTI, FLAIR 3D, QSM).

Sponsors & Collaborators

  • IRCCS Centro Neurolesi Bonino Pulejo

    lead OTHER

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-10
Primary Completion
2020-12-22
Completion
2021-01-10

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06217237 on ClinicalTrials.gov